Neurosciences

Title
CAP2
Trial Number
204901032013
Number of Participants
1,500
Principal Investigator

John J. Lopez

M.D., FACC, FSCAI
Cardiology
Professor
Eligibility

Participants must have non-valvular atrial fibrillation (AF) that requires prophylaxis for potential thrombus formation. A transthoracic and a transesophageal echocardiogram must be completed prior to enrollment to confirm eligibility criteria.

Purpose

The purpose of this study is to provide access to an investigational device used to help prevent blood clot formation in the heart.

Enrollment

(708) 216-2644

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.